Sign in
Active, not recruitingPhase 2

TRPM8 Activators for Peripheral Neuropathy

Key facts

Who runs it
SHIANG-SUO HUANG
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 2
People taking part
60 people enrolled
Started
3 Nov 2025
Ended
1 Jun 2026
Type of study
Interventional
Treatments tested
  • Hand and Foot Mask
Record updated
15 May 2026

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Patients aged 20 years or older who are currently receiving or have previously received chemotherapy and have clinical features of chemotherapy-induced peripheral neuropathy (CIPN)
  • Diabetic patients aged 20 years or older who have clinical features of diabetic peripheral neuropathy (DPN)
  • Patients who meet criteria 1 or 2, are willing to participate, and are able to sign an informed consent form

Who cannot take part

  • Peripheral vascular disease
  • Depression, history of surgery on the hands, feet, or back
  • Skin conditions such as leprosy and connective tissue disorders, familial neuropathy
  • Individuals with allergic symptoms
  • Individuals with a history of convulsions
  • Poorly controlled diabetes (HbA1c > 8%)
  • Chronic kidney disease (eGFR < 30 ml/min/m²)
  • Pregnant or breastfeeding women
  • Individuals with G6PD deficiency (favism)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this pilot prospective cohort study is to evaluate the efficacy of a novel hand and foot mask in alleviating symptoms of peripheral neuropathy caused by chemotherapy or diabetes. The study aims to determine whether regular use of these masks can improve patient comfort and quality of life.

Read full original descriptionShow less

The primary questions this study aims to answer are:

Does the use of the hand and foot mask reduce the severity of symptoms associated with chemotherapy-induced peripheral neuropathy (CIPN) or diabetic peripheral neuropathy (DPN)?

Does the application of the masks improve patient quality of life and treatment compliance for those undergoing chemotherapy?

Participants will:

Complete an initial assessment questionnaire on Day 1.

Apply hand and foot masks daily for 5 minutes, for 7 consecutive days.

Complete a follow-up questionnaire on Day 7 to assess the effects of one week of use.

Inclusion Criteria

Individuals are eligible for the study if they meet the following criteria:

Chemotherapy-Induced Peripheral Neuropathy (CIPN) group:

Age 20 or older.

Currently receiving or having previously received chemotherapy.

Demonstrating clinical signs and symptoms of chemotherapy-induced peripheral neuropathy.

Diabetic Peripheral Neuropathy (DPN) group:

Age 20 or older.

Diagnosed with diabetes mellitus.

Demonstrating clinical signs and symptoms of diabetic peripheral neuropathy.

General requirement:

Participants must be willing to participate and capable of signing the Informed Consent Form (ICF).

The group in the trial

  • treatmentTreatment being tested

    Treatment: Hand and Foot Mask

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Innovative TRPM8 Activators Membrane-Based Delivery System on Peripheral Neuropathy
Record updated
15 May 2026